This inventor holds 1 USPTO granted patent. Top assignee: New York University. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,733 
Years Active: 2019
Title: Mazin Magzoub: Innovator in Cancer Research
Introduction
Mazin Magzoub is a prominent inventor based in Abu Dhabi, AE. He has made significant contributions to the field of cancer research, particularly in the area of p53 mutations. His innovative work focuses on developing solutions to combat diseases associated with these mutations.
Latest Patents
Mazin Magzoub holds a patent titled "Use of oligopyridylamides to inhibit mutant p53 amyloid formation and restore its tumor suppressor function." This invention relates to oligopyridylamide alpha-helix mimetic compounds and their application in inhibiting p53 aggregation. The goal is to restore the tumor suppressor function of p53 for treating cancers linked to p53 mutations, such as the R248W p53 mutation. He has 1 patent to his name.
Career Highlights
Mazin Magzoub is affiliated with New York University, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential impact on treatment strategies for various cancers.
Collaborations
Mazin collaborates with notable colleagues, including Sunil Kumar and Andrew D. Hamilton. Their combined expertise enhances the research efforts in the field of cancer treatment.
Conclusion
Mazin Magzoub's innovative contributions to cancer research highlight the importance of addressing p53 mutations in therapeutic strategies. His work exemplifies the potential of scientific innovation to improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile